On September 25^th, the first meeting of AMCHAM’s Pharmaceuticals Committee for the year 2023-24 was held in Gurugram (in hybrid fashion) under the chairmanship of Mr. Rakesh Bamzai, Chairman – Pharmaceuticals Committee, AMCHAM and MD & CEO, Mylan Laboratories Ltd. and Ms. Neelima Dwivedi, Co-Chairperson –  Pharmaceuticals Committee, AMCHAM and Executive Director, MSD Pharmaceuticals. The meeting was followed by an interactive session with U.S. Embassy officials: Mr. Jonathan Heimer, Honorary National Board Member, AMCHAM and Minister Counselor for Commercial Affairs, Ms. Durra Elmaki, Commercial Officer and Mr. Naveen Rai,  Sr. Commercial Specialist (Policy & Government Relations), U.S. Embassy. Industry Experts from Blackstone, Mylan, Johnson & Johnson,  Baxter and Deloitte participated. The key activities and initiatives proposed for this year would be a signature event, continued stakeholder engagement and policy advocacy, idea exchange forum and elevating the pharma industry as a key contributor to industry wide policy forums. The committee discussed the idea of a pharma industry CSR event and policy doorknock in India. The committee also discussed creating a whitepaper to focus on policy issues that could be shared with both the Indian and U.S. governments.